GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » Debt-to-Equity

CanadaBis Capital (TSXV:CANB) Debt-to-Equity : 0.71 (As of Jan. 2025)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital Debt-to-Equity?

CanadaBis Capital's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2025 was C$2.13 Mil. CanadaBis Capital's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2025 was C$3.82 Mil. CanadaBis Capital's Total Stockholders Equity for the quarter that ended in Jan. 2025 was C$8.42 Mil. CanadaBis Capital's debt to equity for the quarter that ended in Jan. 2025 was 0.71.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for CanadaBis Capital's Debt-to-Equity or its related term are showing as below:

TSXV:CANB' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.66   Med: 1.82   Max: 5.59
Current: 0.71

During the past 9 years, the highest Debt-to-Equity Ratio of CanadaBis Capital was 5.59. The lowest was 0.66. And the median was 1.82.

TSXV:CANB's Debt-to-Equity is ranked worse than
77.45% of 816 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs TSXV:CANB: 0.71

CanadaBis Capital Debt-to-Equity Historical Data

The historical data trend for CanadaBis Capital's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital Debt-to-Equity Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only 1.82 4.88 3.08 1.01 0.81

CanadaBis Capital Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.80 0.81 0.76 0.71

Competitive Comparison of CanadaBis Capital's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Debt-to-Equity falls into.


;
;

CanadaBis Capital Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

CanadaBis Capital's Debt to Equity Ratio for the fiscal year that ended in Jul. 2024 is calculated as

CanadaBis Capital's Debt to Equity Ratio for the quarter that ended in Jan. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (TSXV:CANB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


CanadaBis Capital Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital Business Description

Traded in Other Exchanges
Address
255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.
Executives
Garfield Richards Senior Officer
Shane Chana Director

CanadaBis Capital Headlines

From GuruFocus

Four Cannabis Companies Capitalizing On Increased CBD Demand

By Marketwired Marketwired 08-18-2021